Fairmont & Associates is delighted to announce the addition of a senior healthcare regulatory specialist to its growing Healthcare & Life Sciences sector practice.
The new team member brings over two decades of experience advising leading pharmaceutical manufacturers, medical device companies, and healthcare providers on FDA regulatory compliance, clinical trial agreements, licensing, and healthcare M&A.
"The healthcare and life sciences sector continues to be one of the most dynamic and legally complex industries," said Managing Partner David K. Okafor. "This addition significantly enhances our ability to provide comprehensive, specialized counsel to clients in this space."
The firm's Healthcare & Life Sciences practice now comprises eight dedicated lawyers advising clients across regulatory, transactional, and litigation matters.